A new automatic apparatus based on the differential measurement of pH between two solutions has been developed. Two 25-FL (internal volume) glass capillary electrodes are used to measure the results of automated (under microcomputer control) chemical reactions that lead to the liberation or the uptake of hydrogen ions. The sensitivity of the differential pH measurements is better than ± 0.0001 pH unit, and the change in H concentration that can be detected by such an apparatus is 1 mol/L for plasma and 3 tmol/L for whole blood. 
A new automatic apparatus based on the differential measurement of pH between two solutions has been developed. Two 25-FL (internal volume) glass capillary electrodes are used to measure the results of automated (under microcomputer control) chemical reactions that lead to the liberation or the uptake of hydrogen ions. The sensitivity of the differential pH measurements is better than ± 0.0001 pH unit, and the change in H concentration that can be detected by such an apparatus is 1 mol/L for plasma and 3 tmol/L for whole blood. The technique has been applied to the measurement of glucose in plasma, giving results in agreement with the specifications of the Food and Drug Administration reference method for quantitative determination of glucose (hexokinase/glucose-6-phosphate dehydrogenase method).
Additional Keyphrases: change in pH as related to enzyme activity . glass capillary electrodes
We have previously shown (1) that differences in pH between two solutions can be measured by using two glass electrodes, and we have applied this technique to the determination of glucose in aqueous solutions by measuring the change in pH produced by the hexokinase-catalyzed ATP-glucose reaction (2). The sensitivity of the method was about 5 x io-pH units, indicating that the pH method might be useful in the measurement of analytes of analytical and climco-chemical interest. However, our previously described apparatus was not suitable for routine work and we sought to develop a fully automated instrument that could perform a variety of analytical functions, i.e., addition of reagents, filling and standardization of the electrodes, and calculation of results.
Here we describe this new instrument and report the results of its application to the routine determination of glucose in plasma. We have also developed theoretical equations that predict the sensitivity of the method when applied to the determination of analytes in human plasma or whole blood.
Materials and Methods

The Differential pH System
The basic components of the apparatus are shown schematically in Figure 1 . Cuvette C is filled by the peristaltic pump P2 with a buffer from a separate reservoir (not shown). By means of the peristaltic pump P3 the content of the cuvette can be brought to constant volume (typically about 800 iL). The contents of cuvette C can be mixed by magnet N, which is covered with inert plastic, magnetically coupled to another magnet, and driven by motor M. All measurements with the pH apparatus described in Figure 1 Whenever the addition caused a change in pH, we added acid or base to bring the specimen back to its initial value.
For each interfering substance used we compared values for 26 specimens with and without the addition of the interfering substance. It is also apparent that in the pH range 7.4-7.5 the effect of temperature on n is negligible. Figure 2b shows how the buffer value of the standard buffer changes with pH over the pH interval 7.3-7.5, at 25 and 37 #{176}C. (d) Blank: in this cycle no standard or sample is added, and the effect of the addition of the enzyme to the pH of the solution is determined (pH0).
Results
about 300 .tL of solution is aspirated by pumps P4 and P5 into electrodes El and E2. Pump P1 then injects into cuvette C a known quantity of hexokinase solution (typically 5 L), motor M is activated for another 2 s,and pump P5
Determination of Glucose
When glucose is placed in a solution containing ATP in the presence of the enzyme hexokinase, ADP and glucose 6-phosphate (G6P) are formed, and the equilibrium
Because the PKa of ATP differs from those of G6P and ADP, the pH of the solution changes during the reaction course. The actual reaction that occurs in solution at pH 7.5 can be written symbolically
where ATP, ADP, and G6P represent all of the different charged species in the solution for ATP, ADP, and G6P, respectively, and n is the number of hydrogen ions produced in the reaction. Therefore the liberation of n protons provides a means of determining the concentration of glucose in the original sample.
Chemicals and solutions.
Hexokinase (ATP:n-hexose 6-phosphotransferase, EC 2.7.1.1) was obtained from Sigma Chemical Co., St. Louis, MO 63178, as a lyophilized powder. We generally do not recommend using enzymes suspended in concentrated ammonium sulfate or in strong buffers for this work, because their addition to the solution may considerably change its buffer power. ATP (sodium salt, trihydrate)
and NAD (free acid) were obtained from Boehringer, Mannheim, F.R.G. Sterox SE was purchased from Baker Chemicals, Deventer, Holland. Certified National Bureau of Standards (NBS) i( + )-glucose and G6P dehydrogenase (n-glucose-6-phosphate:NADP 1-oxidoreductase, EC 1.1.1.49) were a generous gift from Ames Miles, Milano, Italy. Carbon dioxide-free water and reagent water were prepared as described (3). All other reagents were analytical grade.
The buffer medium used in this work to study reaction 2 (hereafterreferred to as "standard buffer")has the composi-
ATP (1.4 mmolIL), pH 7.50 (at 25 #{176}C). The stability of the standard buffer was assessed by measuring the change in pH, ATP concentration, and hexokinase activity after storage in stoppered containers.
The pH and ATP concentrations were stable for at least six days in room temperature. The hexokinase, however, lost 17% and 37% of its activity after one and three days, respectively, at room temperature (-0% and 18%, respectively, after one and two days at 5 #{176}C). We therefore dissolved the hexokmase in 0.5 mL of standard buffer just before use to give a final concentration of 850 kU/ L.
To prepare the working glucose standard we dissolved standard amounts of anhydrous n( + )-glucose in 100 mL of 0.1 mol/L KCI containing 0.5 g of NaN3 per liter. The Data obtained by use of the standard Radiometer titration system and confirmed by experiments with the pH apparatus. The concentrationof glucose(abscissa) is that of the undilutedsample concentration.In fact,at a glucose concentrationof 4.00 g/L the deviation from linearityisless than 2.5%. The deviation increases to about 8% when the glucose concentration is 10.00 g/L, a value 10-fold greater than the normal plasma value. Each point is the mean of two determinations
Discussion
Apparatus and Performance
Because the sample is also diluted from a volume V8 to V5/ (V5 + Vb), the total change of [B] or 1W] in the undiluted sample will be given by
For finite increments, equation 5 becomes
The sensitivity (5) (b) the addition to the pH system of a reactor (cuvette C, Figure 1 ) with a known volume, in which a solution (or a suspension) containing an analyte may be diluted in a proper buffering medium and reacted with a suitable reagent, such as an enzyme; and (c) the adoption of a microcomputer to direct the operation of the system and calculate the concentration of the analyte of interest. 
The buffer power of standard buffer Pbshould be changed from Pbto Pb' totake into account the effect of the addition of plasma on the pH and hence on the Pbof standard buffer.In fact, the effect is very small. If/3,, = 9.4 x i0 and the pH variation in individual plasma samples does not exceed ± 0.5 pH unit,the total amount of base or acid added to the standard would be at most ±9,4 x 0,5 x 10-/81 = ±58 zmoLfL, causing a maximum change of(±5.8 x 10-)/(5.8 x 10-s) = ±0.01 pH unit in the standard buffer. This corresponds to a total maximum change of 1% in Pb (Figure   2b ). Thus the effect of analyzing plasma samples with extreme pH values (i.e., 6.9-7.9) has only a negligible effect on the determination of their glucose content by this method.
Because, under the experimental conditions chosen, pHo' zpH0"
XpH0", equations 10 and 11 can be combined, giving:
The determination of glucose in plasma by use of equation [glucose]5 = 2.00 g/L) have been corrected as follows: #{149} for the residual nonlinearity between glucose concentration and ipH ( Figure 3b) ; the size of this correction is, at most, 2.5% of the value of glucose concentration at the highest limit of glucose concentration studied (4.00 g/L). #{149} for the small (less than 0.5%) effect of changing the buffer value of the standard buffer after the addition of plasma. for plasma and 51 moI1L for whole blood. Therefore, under the conditions of our experiments, the contribution of the buffer value of plasma and of whole blood to the total buffer value of standard buffer is very small, i.e., 0.04/5.84 = 0.7% (plasma) and 0.30/6.10 = 4,9% (whole blood).
Determination of Glucose in Plasma
In a blank cycle the effect of addition of enzyme solution to standard buffer is first determined. [glucose]5 = f x B x (pH1 -ApH0") where f is the dilution coefficient = (Vb + V5 + V5)/V5. A measuring cycle is then performed by the addition of a known volume (10 juL) of plasma with an unknown glucose concentration. Again assuming a linear relationship between glucose concentration and pH, then:
for the volume effect due to plasma proteins, a correction made according to the following equation (5): c = c1([100/ (100 -Vc,,,)I -1), where c1 = concentration of glucose in plasma, c2 = concentration of glucose in the protein-free supernate, c = c2 -c1, c,, = concentration of protein in g/ dl, and V = mean partial specific volume of the proteins. c calculated from the above formula is, for human plasma of normal protein content, less than 5% of the value of the glucose concentration.
The correction is based on the assumption that in the FDA reference method there is no coprecipitatedor adsorbed glucose in the precipitate. Table 2 shows the effect on the mean glucose concentration of various interfering substances. Clearly, only fructose interferes significantly. This is to be expected because hexokinase is known to catalyze the phosphorylation of both glucose and fructose. However, Km for glucose is 1.0 x 1O mol/L as compared with 7.0 x iO mol/L for fructose (6) , which probably explains why fructose interference is equivalent to less than half of its total concentration.
Other carbohydrates (e.g., galactose
and xylose) or disaccharides (maltose and lactose) do not produce an appreciable effect.
We were interested at this point to see whether the simplified method of enzymatic analysis of glucose concentration based on reaction 2 and pH measurement would qualify as an FDA in vitro diagnostic device for the quanti- No value of glucose concentration by the tpH method was found to differ by more than 15% of the value obtained by the reference FDA method. Analysis of data on the specificity of the pH method (Table 2) showed that the effect of all substances tested, including fructose, was within the interference limit set by the FDA specifications.
The small discrepancy (averaging about 0.04 g/L) between glucose concentrationsdetermined by the pH method with a single enzyme and by the FDA reference method was probably due to the simultaneous phosphorylation of fructose as well as of glucose when only hexokinase was used.
However, the fructose concentration in plasma of normal fasting individualsisvery small (7), probably 0.02-0.04 g/L, and would not introduce clinically relevant errors.
